Average Co-Inventor Count = 4.85
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (19 from 2,405 patents)
2. Merck + Co., Inc. (7 from 4,770 patents)
3. Princeton University (2 from 1,079 patents)
4. Merck Sharp + Dohme B.v. (1 from 55 patents)
28 patents:
1. 12246008 - 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
2. 11884683 - Tricyclic heterocycle compounds useful as HIV integrase inhibitors
3. 10968210 - Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
4. 10519147 - Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
5. 10221167 - Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels
6. 10011595 - Ethyldiamine orexin receptor antagonists
7. 9938276 - 6,5-bicyclic octahydropyrrolopyridine orexin receptor antagonists
8. 9834554 - BTK inhibitors
9. 9718828 - BTK Inhibitors
10. 9637486 - Btk inhibitors
11. 9481682 - Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors
12. 9446130 - BTK inhibitors
13. 8895583 - Soluble guanylate cyclase activators
14. 8507512 - Soluble guanylate cyclase activators
15. 8455638 - Soluble guanylate cyclase activators